Results 61 to 70 of about 173,404 (232)

Stress-induced cardiomyopathy after nephrectomy in a patient with a kidney cancer: a case report

open access: yesКардиоваскулярная терапия и профилактика, 2020
Stress-induced (takotsubo) cardiomyopathy is a rare disease, which characterized by transient left ventricle dysfunction in response to a trigger factor (stress or severe somatic disease with surgical intervention) and is manifested by symptoms of acute ...
O. P. Kotova   +3 more
doaj   +1 more source

Takotsubo Cardiomyopathy after Elective Aortic and Mitral Valve Replacement [PDF]

open access: yesFolia Medica, 2020
Takotsubo cardiomyopathy is a syndrome characterized by transient acute left ventricular dysfunction, electrocardiographic changes that can mimic acute myocardial infarction and minimal release of myocardial enzymes in the absence of obstructive coronary
Zaprin Vazhev, Hristo Stoev
doaj   +3 more sources

Intraventricular thrombus and severe mitral regurgitation in the acute phase of takotsubo cardiomyopathy: two case reports

open access: yesJournal of Medical Case Reports, 2019
Background Takotsubo cardiomyopathy is characterized by chest symptoms, electrocardiographic changes, and new regional wall motion abnormality in the apical segment of the left ventricle in the absence of obstructive coronary artery disease. Particularly,
Daishi Nonaka   +3 more
doaj   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Takotsubo cardiomyopathy in a snake bite victim: a case report

open access: yesThe Pan African Medical Journal, 2012
Takotsubo cardiomyopathy, also called stress-induced cardiomyopathy or transient apical ballooning, has been described as a novel cardiac syndrome of left ventricular apical ballooning, electrocardiographic changes, and minimal elevation of cardiac ...
Kichiro Murase, Kenji Takagi
doaj   +1 more source

Síndrome de takotsubo secundario a traumatismo raquimedular

open access: yesRevista Colombiana de Cardiología, 2018
Resumen: Antecedentes: El síndrome de takotsubo secundario a traumatismo raquimedular cervical es infrecuente y no se describen series de casos en la literatura.
María Ortiz-Lasa   +4 more
doaj   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher   +12 more
wiley   +1 more source

Areas of research priorities in epilepsy: A position paper of the European Reference Network for Rare and Complex Epilepsies, EpiCARE

open access: yesEpilepsia Open, EarlyView.
Abstract Objective To define and articulate research priorities in epilepsy identified by the European Reference Network for Rare and Complex Epilepsies (ERN EpiCARE), addressing key unmet needs across the spectrum of rare and complex epilepsies. Methods This position paper was developed through a structured collaborative process involving patient ...
Sébile Tchaicha   +27 more
wiley   +1 more source

COVID-19-Associated Stress (Takotsubo) Cardiomyopathy.

open access: yesCirculation Cardiovascular Imaging, 2020
July 2020 1 Connie W. Tsao, MD, MPH Jordan B. Strom, MD, MSc James D. Chang, MD Warren J. Manning, MD Coronavirus disease 2019 (COVID-19) infection has resulted in an unprecedented number of critical care hospitalizations and substantial mortality across
C. Tsao, J. Strom, J. Chang, W. Manning
semanticscholar   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy